What does ACADIA Pharmaceuticals, Inc. do?

Jun 22 2025 06:43 PM IST
share
Share Via
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing medicines for central nervous system disorders, with a recent market cap of approximately $3.82 billion and net sales of $244 million. The company has a P/E ratio of 16.00 and no dividend yield.
Overview:
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing medicines for central nervous system disorders, operating within the Pharmaceuticals & Biotechnology industry and classified as a small-cap company.

Financial Snapshot:
Most recent Net Sales: 244 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 19 Million (Quarterly Results - Mar 2025)
Market-cap: USD 3,815.85 Million (Small Cap)

Key Metrics:
P/E: 16.00
Dividend Yield: 0.00%
Debt Equity: -0.88
Return on Equity: 29.91%
Price to Book: 4.99

Contact Details:
Address: 3611 Valley Centre Dr Ste 300, SAN DIEGO CA: 92130-3331
Tel: 1 858 5582871
Fax: 1 858 5582872
Website: http://www.acadia-pharm.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News